Use of Fish Scale-Derived BioCornea to Seal Full-Thickness Corneal Perforations in Pig Models

The aim of this study was to test the use of BioCornea, a fish scale-derived collagen matrix for sealing full-thickness corneal perforations in mini-pigs. Two series of experiments were carried out in 8 Lan-Yu and 3 Göttingen mini-pigs, respectively. A 2mm central full thickness corneal perforation...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 10; no. 11; p. e0143511
Main Authors Chen, Shih-Cheng, Telinius, Niklas, Lin, Han-Tse, Huang, Min-Chang, Lin, Chien-Chen, Chou, Cheng-Hung, Hjortdal, Jesper
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 24.11.2015
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The aim of this study was to test the use of BioCornea, a fish scale-derived collagen matrix for sealing full-thickness corneal perforations in mini-pigs. Two series of experiments were carried out in 8 Lan-Yu and 3 Göttingen mini-pigs, respectively. A 2mm central full thickness corneal perforation was made with surgical scissors and 2mm trephines. The perforations were sealed immediately by suturing BioCornea to the wounded cornea. The conditions of each patched cornea were followed-up daily for 3 or 4 days. Status of operated eyes was assessed with slit lamp examination or optical coherence tomography (OCT). Animals were sacrificed after the study period and the corneas operated were fixated for histological examination. Both OCT imaging and handheld slit lamp observations indicated that a stable ocular integrity of the perforated corneas was maintained, showing no leakage of aqueous humor, normal depth of anterior chamber and only mild swelling of the wounded cornea. Hematoxylin and eosin staining of the patched cornea showed no epithelial ingrowths to the perforated wounds and no severe leucocyte infiltration of the stroma. The fish scale-derived BioCornea is capable to seal full-thickness corneal perforation and stabilize the integrity of ocular anterior chamber in pre-clinic mini-pig models. BioCornea seems to be a safe and effective alternative for emergency treatment of corneal perforations.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Conceived and designed the experiments: SCC CCL CHC JH. Performed the experiments: NT HTL CHC JH. Analyzed the data: SCC NT JH. Contributed reagents/materials/analysis tools: CCL MCH. Wrote the paper: SCC NT JH.
Competing Interests: Aeon Astron Europe sponsored all experiments. The expenditures associated with the experiments were covered by Aeon Astron Europe B.V. and Body Organ Biomedical Corp. Shih-Cheng Chen is employed by Aeon Astron Europe B.V. and Han-Tse Lin, Min-Chang Huang, Chien-Chen Lin and Cheng-Hung Chou by Body Organ Biomedical Corp. JH and NT received no funding or any form for financial compensation for their contribution. BioCornea is part of Patent US 7,838,038 B2 (Biomaterial and preparation method thereof). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0143511